Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Maintenance in Older Patients With Mantle Cell Lymphoma
NCT00727207Phase 2Terminated
- Sponsor
- Technical University of Munich
- Start
- May 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in mantle cell lymphoma (MCL), sponsored by Technical University of Munich. Started May 2008; status: terminated.
02
Drugs
everolimus
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00727207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00727207.